Mycostatin

Vulvovaginal Candidiasis, Low; Birthweight, Anal candidiasis + 13 more
Treatment
20 Active Studies for Mycostatin

What is Mycostatin

NystatinThe Generic name of this drug
Treatment SummaryNystatin is a medication used to treat fungal infections caused by certain types of yeast and fungi. It is derived from a strain of the bacteria Streptomyces noursei and is closely related to Amphotericin B. Nystatin is more effective than Amphotericin B, but is not suitable for systemic use due to toxicity. It is usually administered orally or topically and it is not absorbed into the body, so it only works on the surface of the skin, mucous membranes, or gastrointestinal tract.
Nystatinis the brand name
Mycostatin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Nystatin
Nystatin
1979
252

Effectiveness

How Mycostatin Affects PatientsNystatin is an antifungal drug that can stop the growth and spread of certain kinds of fungi. It works by affecting the cell membrane surrounding the fungus. While it is generally very effective against _Candida albicans_, other types of _Candida_ may become resistant to it. Nystatin does not affect bacteria, protozoa, or viruses. It cannot be used to treat systemic infections, so it must be applied topically, orally, or in the gastrointestinal tract.
How Mycostatin works in the bodyNystatin works by creating pores in the cell walls of fungi. This increases the permeability of the cell wall, allowing the contents inside the cell to leak out, leading to disruption of how the cell works. Nystatin is able to target fungal cells more effectively than mammalian cells because it has a stronger bond to ergosterol, which is a sterol found in fungal cell walls, than cholesterol, which is found in mammalian cell walls.

When to interrupt dosage

The suggested dosage of Mycostatin is contingent upon the recognized condition, such as cutaneous candidiasis, Skin candida and corticosteroid-responsive dermatoses. The measure of dosage fluctuates, in light of the technique of conveyance (e.g. Insert or Insert - Vaginal) presented in the table beneath.
Condition
Dosage
Administration
cutaneous candidiasis
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Skin candida
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
corticosteroid-responsive dermatoses
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Vaginal Candidiasis
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Pruritus Ani
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Urinary Tract Infection (UTI)
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Pruritus Vulvae
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Candidiasis, Invasive
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Yeast Infection
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Trichomonas Vaginitis
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Vulvovaginal Candidiasis
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Low; Birthweight
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Anal candidiasis
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Oral Candidiasis
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Candida albicans
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral
Intestinal Candidiasis
, 10000.0 [USP'U]/mL, 100000.0 units, 100.0 [USP'U]/mg, 100000.0 units/mL, 100.0 mg/mg, 100000.0 [USP'U]/mL, 100.0 units/mg, 25.0 units/mg, 500000.0 [USP'U], 500000.0 [USP'U]/mL, 500000.0 units, 100000.0 [USP'U], 100000.0 [iU]/mL, 6.75 mg/mL, 6.0 mg/mg, 1000000.0 units, 200000.0 units, 1.2 mg/mg
Insert, Insert - Vaginal, , Topical, Kit, Suspension - Oral, Cream, Ointment, Powder, Solution / drops, Tablet - Oral, Vaginal, Oral; Topical, Tablet, Suppository - Vaginal, Cream - Topical, Ointment - Topical, Oral, Solution, Kit - Oral, Lozenge - Oral, Tablet - Vaginal, Solution - Oral, Suspension, Liquid, Suppository, Capsule - Oral, Cream - Vaginal, Capsule, Solution / drops - Oral, Powder - Topical, Lozenge, Powder, for suspension - Oral, Liquid - Oral, Tablet, coated, Kit - Topical, Powder, for suspension, Tablet, film coated - Oral, Cream - Oral; Topical, Cream - Oral, Tablet, film coated, Tablet, coated - Oral

Warnings

Mycostatin has one contraindication, so it should not be merged with the conditions found in the following table.Mycostatin Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Nystatin may interact with Toxoplasma Infections
There are 20 known major drug interactions with Mycostatin.
Common Mycostatin Drug Interactions
Drug Name
Risk Level
Description
Revefenacin
Major
Nystatin may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Vazegepant
Major
The serum concentration of Zavegepant can be increased when it is combined with Nystatin.
Ambrisentan
Minor
The excretion of Ambrisentan can be decreased when combined with Nystatin.
Asunaprevir
Minor
The excretion of Asunaprevir can be decreased when combined with Nystatin.
Atorvastatin
Minor
The excretion of Atorvastatin can be decreased when combined with Nystatin.
Mycostatin Toxicity & Overdose RiskThe lowest toxic dose of nystatin in rats is 10 g/kg. Taking too much nystatin can cause nausea and stomach pain, but no other serious side effects have been reported, even when doses of up to five million units are taken in one day.

Mycostatin Novel Uses: Which Conditions Have a Clinical Trial Featuring Mycostatin?

39 active clinical trials are currently being conducted to examine the potential of Mycostatin to mitigate Urinary Tract Infection, Yeast Infection and Anal Itching.
Condition
Clinical Trials
Trial Phases
Urinary Tract Infection (UTI)
25 Actively Recruiting
Phase 2, Phase 1, Phase 4, Phase 3, Not Applicable
Yeast Infection
9 Actively Recruiting
Phase 3, Phase 1, Phase 2, Early Phase 1
Pruritus Ani
0 Actively Recruiting
Intestinal Candidiasis
0 Actively Recruiting
Vaginal Candidiasis
0 Actively Recruiting
Oral Candidiasis
0 Actively Recruiting
Vulvovaginal Candidiasis
2 Actively Recruiting
Phase 3, Early Phase 1
Skin candida
0 Actively Recruiting
Anal candidiasis
0 Actively Recruiting
Candidiasis, Invasive
4 Actively Recruiting
Phase 3
Low; Birthweight
1 Actively Recruiting
Not Applicable
Trichomonas Vaginitis
1 Actively Recruiting
Phase 2
corticosteroid-responsive dermatoses
0 Actively Recruiting
Candida albicans
0 Actively Recruiting
Pruritus Vulvae
0 Actively Recruiting
cutaneous candidiasis
0 Actively Recruiting

Mycostatin Reviews: What are patients saying about Mycostatin?

5Patient Review
10/9/2008
Mycostatin for Thrush
This was easy to take and I didn't mind the taste. Most importantly, it worked great!
5Patient Review
2/20/2011
Mycostatin for Stomach and Intestinal Infection caused by the Fungus Candida
This medication is effective, but I was told that I have to take it regularly in order to manage my candida. So far, no side effects and I feel really good after taking it!
4Patient Review
10/24/2020
Mycostatin for Candida Fungus Infection of Mouth, Skin, Nails or Vagina
I just started using Mycastatin. I find it very easy to use--the taste is not bad, slight bitterness that one can tolerate. I have not completed treatment yet so I cannot speak to its effectiveness; however, I will return and update this review once I am finished.
3.7Patient Review
12/15/2007
Mycostatin for Thrush
The taste is really off-putting, but it works well enough that I can overlook it.
3.7Patient Review
7/18/2012
Mycostatin for Candida Fungus Infection of Mouth, Skin, Nails or Vagina
The taste is incredibly unpleasant, but it's worth it for the results.

Patient Q&A Section about mycostatin

What is mycostatin used for?

"This medication, Nystatin, is used to treat fungal infections of the mouth. It works by stopping the growth of fungus. Nystatin suspension should not be used, however, to treat fungal infections of the blood." - Anonymous Online Contributor

Unverified Answer

Is nystatin and mycostatin the same?

"Nystatin is an antibiotic that is used to treat fungal infections. It is available as a cream or powder." - Anonymous Online Contributor

Unverified Answer

How long does it take mycostatin to work?

"It is typically recommended to take nystatin liquid four times a day, approximately 30 minutes after eating or drinking. The medication usually begins to work after two days, though it is important to continue using it for two days after symptoms have improved." - Anonymous Online Contributor

Unverified Answer

What is the generic name for mycostatin?

"brand names for Nystatin include Mycostatin, Nilstat, Nyamyc, Nystat Rx, Nystatin Systemic, Nystex, and Nystop." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Clinical Trials for Mycostatin

Have you considered Mycostatin clinical trials? We made a collection of clinical trials featuring Mycostatin, we think they might fit your search criteria.
Have you considered Mycostatin clinical trials? We made a collection of clinical trials featuring Mycostatin, we think they might fit your search criteria.
Have you considered Mycostatin clinical trials? We made a collection of clinical trials featuring Mycostatin, we think they might fit your search criteria.